Search details
1.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 700-705, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38696053
2.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 689-699, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38578596
3.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38353907
4.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38494578
5.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38526621
6.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38538963
7.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38755516
8.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(6): 681-688, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38649648
9.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38517658
10.
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Br J Haematol
; 192(3): 531-541, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32583431
11.
[Reduced-intensity umbilical cord blood transplantation for adult patients with fulminant aplastic anemia].
Rinsho Ketsueki
; 59(1): 64-68, 2018.
Article
in Japanese
| MEDLINE | ID: mdl-29415940
12.
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
Cancer Sci
; 113(9): 3267-3270, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35909244
13.
Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
Ann Hematol
; 94(3): 491-6, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25325985
14.
Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.
Intern Med
; 63(7): 993-998, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-37558474
15.
Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme.
Br J Haematol
; 169(1): 138-42, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25303008
16.
[High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].
Gan To Kagaku Ryoho
; 37(7): 1277-82, 2010 Jul.
Article
in Japanese
| MEDLINE | ID: mdl-20647709
17.
Fractionated administration of gemtuzumab ozogamicin for refractory acute myeloid leukemia.
Rinsho Ketsueki
; 50(11): 1601-6, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-20009433
18.
Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.
Gan To Kagaku Ryoho
; 36(7): 1105-9, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19620797
19.
Clinical significance of cancer-related fatigue in multiple myeloma patients.
Int J Hematol
; 108(6): 580-587, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30155589
20.
Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
Intern Med
; 56(6): 701-706, 2017.
Article
in English
| MEDLINE | ID: mdl-28321074